Clinical Trial Update: Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a clofarabine and busulfan conditioning regimen before stem cell transplantation for leukemia and myelodysplastic syndromes ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (clofarabine)

Snippet

Sponsor: Baylor Research Institute | Conditions: Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED